Avricore Health Inc. AVCRF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 163.77% | -89.45% | -97.64% | -96.87% | -97.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 163.77% | -89.45% | -97.64% | -96.87% | -97.29% |
| Cost of Revenue | -3.42% | -37.91% | -95.08% | -88.25% | -88.74% |
| Gross Profit | 102.87% | -102.57% | -101.23% | -111.98% | -112.84% |
| SG&A Expenses | -44.64% | -44.17% | -34.11% | -46.54% | 32.77% |
| Depreciation & Amortization | -- | 287.50% | -271.43% | 100.00% | 60.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -38.16% | -42.32% | -72.21% | -69.95% | -51.34% |
| Operating Income | 51.03% | -261.06% | -496.71% | -136.90% | -727.55% |
| Income Before Tax | 41.56% | -173.28% | -32.91% | -109.75% | -940.00% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 41.56% | -173.28% | -32.91% | -109.75% | -940.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 41.56% | -173.28% | -32.91% | -109.75% | -940.00% |
| EBIT | 51.03% | -261.06% | -496.71% | -136.90% | -727.55% |
| EBITDA | 48.17% | -698.99% | -264.14% | -843.25% | -328.11% |
| EPS Basic | 45.45% | -200.00% | -34.00% | -107.69% | -925.00% |
| Normalized Basic EPS | 40.00% | -200.00% | -475.00% | -112.50% | -1,100.00% |
| EPS Diluted | 45.45% | -200.00% | -34.00% | -107.69% | -925.00% |
| Normalized Diluted EPS | 40.00% | -200.00% | -475.00% | -112.50% | -1,100.00% |
| Average Basic Shares Outstanding | 3.54% | 0.00% | 0.05% | 0.89% | 1.42% |
| Average Diluted Shares Outstanding | 3.54% | 0.00% | 0.05% | 0.89% | -4.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |